Tan et al. in 2016 reported the first CD8+ T-cell response against mutant KRAS G12D in tumor-infiltrating lymphocytes (TILs) obtained from a patient with metastatic colorectal cancer. The gene discussed is KRAS; the disease is neoplasm.